Patterns and costs associated with progression of age-related macular degeneration

American Journal of Ophthalmology

Volumn 154, Issue 4, 2012, Pages 675-681.e1

  Schmier, Jordana K ^a   Covert, David W ^b   Lau, Edmund C ^a  

^a EXPONENT INC   (United States)

^b ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN;

AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DISEASE COURSE; FEMALE; HEALTH CARE COST; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICARE; POPULATION; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION;

EID: 84866358655     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2012.04.017     Document Type: Article

References (37)

1. N.M. Bressler, S.B. Bressler, N.G. Congdon Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11 Arch Ophthalmol 121 11 2003 1621 1624 (Pubitemid 37392370)
2. N.M. Bressler Age-related macular degeneration is the leading cause of blindness JAMA 291 15 2004 1900 1901 (Pubitemid 38509505)
3. D.S. Friedman, B.J. O'Colmain, B. Munoz Prevalence of age-related macular degeneration in the United States Arch Ophthalmol 122 2004 564 572 (Pubitemid 38456293)
4. Age-Related Eye Disease Study Research Group Risk factors associated with age-related macular degeneration A case-control study in the age-related eye disease study: Age-Related Eye Disease Study report number 3 Ophthalmology 107 12 2000 2224 2232
5. C. Augood, A. Fletcher, G. Bentham Methods for a population-based study of the prevalence of and risk factors for age-related maculopathy and macular degeneration in elderly European populations: the EUREYE study Ophthalmic Epidemiol 11 2 2004 117 129 (Pubitemid 38530466)
6. P. Darzins, P. Mitchell, R.F. Heller Sun exposure and age-related macular degeneration An Australian case-control study Ophthalmology 104 5 1997 770 776 (Pubitemid 27200873)
7. S.S. Dhubhghaill, M.T. Cahill, M. Campbell, L. Cassidy, M.M. Humphries, P. Humphries The pathophysiology of cigarette smoking and age-related macular degeneration Adv Exp Med Biol 664 2010 437 446
8. R. Klein, B.E. Klein, S.C. Jensen, S.M. Meuer The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study Ophthalmology 104 1 1997 7 21 (Pubitemid 27081937)
9. W. Smith, J. Assink, R. Klein Risk factors for age-related macular degeneration: pooled findings from three continents Ophthalmology 108 4 2001 697 704 (Pubitemid 32238465)
10. S.C. Tomany, J.J. Wang, R. Van Leeuwen Risk factors for incident age-related macular degeneration: pooled findings from 3 continents Ophthalmology 111 7 2004 1280 1287 (Pubitemid 38844822)
11. R. van Leeuwen, C.C. Klaver, J.R. Vingerling, A. Hofman, P.T. de Jong The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam Study Arch Ophthalmol 121 4 2003 519 526 (Pubitemid 36427639)
12. R. Klein, B.E. Klein, M.D. Knudtson, S.M. Meuer, M. Swift, R.E. Gangnon Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study Ophthalmology 114 2 2007 253 262 (Pubitemid 46161820)
13. J.P. Sarks, S.H. Sarks, M.C. Killingsworth Evolution of geographic atrophy of the retinal pigment epithelium Eye (Lond) 2 Pt 5 1988 552 577 (Pubitemid 19142671)
14. Macular Degeneration Partnership What is AMD? http://www.amd.org/what-is- amd.html Accessed April 11, 2012
15. J.S. Sunness The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration Mol Vis 5 1999 25
16. R. Klein, B.E. Klein, S.C. Tomany, S.M. Meuer, G.H. Huang Ten-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study Ophthalmology 109 10 2002 1767 1779
17. D.M. Brown, P.K. Kaiser, M. Michels Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1432 1444 (Pubitemid 44511558)
18. P.J. Rosenfeld, D.M. Brown, J.S. Heier Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1419 1431 (Pubitemid 44511557)
19. A.L. Coleman, F. Yu Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999 Ophthalmology 115 1 2008 18 25
20. A.F. Cruess, G. Zlateva, X. Xu Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study Pharmacoeconomics 26 1 2008 57 73
21. M.T. Halpern, J.K. Schmier, D. Covert, K. Venkataraman Resource utilization and costs of age-related macular degeneration Health Care Financ Rev 27 3 2006 37 47 (Pubitemid 43841078)
22. K.M. Ke The direct, indirect and intangible costs of visual impairment caused by neovascular age-related macular degeneration Eur J Health Econ 11 6 2009 525 531
23. J.K. Schmier, M.L. Jones, M.T. Halpern The burden of age-related macular degeneration Pharmacoeconomics 24 4 2006 319 334
24. D.B. Rein, J.S. Wittenborn, X. Zhang, A.A. Honeycutt, S.B. Lesesne, J. Saaddine Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments Arch Ophthalmol 127 4 2009 533 540
25. T.Y. Wong, U. Chakravarthy, R. Klein The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis Ophthalmology 115 1 2008 116 126
26. E.Y. Chew, R.D. Sperduto, R.C. Milton Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25 Ophthalmology 116 2 2009 297 303
27. J.M. Seddon, R. Reynolds, Y. Yu, M.J. Daly, B. Rosner Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors Ophthalmology 118 11 2011 2203 2211
28. M.L. Klein, P.J. Francis, F.L. Ferris 3rd, S.C. Hamon, T.E. Clemons Risk assessment model for development of advanced age-related macular degeneration Arch Ophthalmol 129 12 2011 1543 1550
29. J.K. Schmier, M.T. Halpern, D. Covert, J. Delgado, S. Sharma Impact of visual impairment on use of caregiving by individuals with age-related macular degeneration Retina 26 9 2006 1056 1062 (Pubitemid 44973226)
30. J.K. Schmier, M.T. Halpern, D.W. Covert, J. Delgado, S. Sharma Impact of visual impairment on service and device use by individuals with age-related macular degeneration (AMD) Disabil Rehabil 28 21 2006 1331 1337
31. G. Soubrane, A. Cruess, A. Lotery Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study Arch Ophthalmol 125 9 2007 1249 1254 (Pubitemid 47403034)
32. G.C. Brown Vision and quality-of-life Trans Am Ophthalmol Soc 97 1999 473 511 (Pubitemid 30106064)
33. E.M. Chia, P. Mitchell, E. Rochtchina, S. Foran, J.J. Wang Unilateral visual impairment and health related quality of life: the Blue Mountains Eye Study Br J Ophthalmol 87 4 2003 392 395 (Pubitemid 36399022)
34. S. Sharma, G.C. Brown, M.M. Brown Converting visual acuity to utilities Can J Ophthalmol 35 5 2000 267 272
35. H.T. Vu, J.E. Keeffe, C.A. McCarty, H.R. Taylor Impact of unilateral and bilateral vision loss on quality of life Br J Ophthalmol 89 3 2005 360 363 (Pubitemid 40327623)
36. R.J. Brechner, P.J. Rosenfeld, J.D. Babish, S. Caplan Pharmacotherapy for neovascular age-related macular degeneration: an analysis of the 100% 2008 Medicare fee-for-service Part B claims file Am J Ophthalmol 151 5 2011 887 895 e881
37. P.S. Bernstein Nutritional interventions against age-related macular degeneration Acta Hortic 841 2009 103 112